Hemoglobinopathies Drugs Market

List of Tables
Table 1. Hemoglobinopathies Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Hemoglobinopathies Drugs Market Trends
Table 3. Hemoglobinopathies Drugs Market Drivers
Table 4. Hemoglobinopathies Drugs Market Challenges
Table 5. Hemoglobinopathies Drugs Market Restraints
Table 6. Global Hemoglobinopathies Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Hemoglobinopathies Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Hemoglobinopathies Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Hemoglobinopathies Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Hemoglobinopathies Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Hemoglobinopathies Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Hemoglobinopathies Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Hemoglobinopathies Drugs Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Hemoglobinopathies Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Hemoglobinopathies Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Hemoglobinopathies Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hemoglobinopathies Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathies Drugs as of 2021)
Table 18. Top Players of Hemoglobinopathies Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Hemoglobinopathies Drugs Product Type
Table 20. Date of International Manufacturers Enter into Hemoglobinopathies Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Hemoglobinopathies Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Hemoglobinopathies Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Hemoglobinopathies Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Hemoglobinopathies Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Hemoglobinopathies Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Hemoglobinopathies Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Hemoglobinopathies Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Hemoglobinopathies Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Hemoglobinopathies Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Hemoglobinopathies Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Hemoglobinopathies Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Hemoglobinopathies Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Hemoglobinopathies Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Hemoglobinopathies Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Hemoglobinopathies Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Hemoglobinopathies Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Hemoglobinopathies Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Hemoglobinopathies Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Hemoglobinopathies Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Hemoglobinopathies Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Gamida Cell Corporation Information
Table 43. Gamida Cell Description and Business Overview
Table 44. Gamida Cell Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Gamida Cell Hemoglobinopathies Drugs Product
Table 46. Gamida Cell Recent Development
Table 47. Alnylam Pharmaceuticals Corporation Information
Table 48. Alnylam Pharmaceuticals Description and Business Overview
Table 49. Alnylam Pharmaceuticals Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Alnylam Pharmaceuticals Product
Table 51. Alnylam Pharmaceuticals Recent Development
Table 52. Biogen Idec Corporation Information
Table 53. Biogen Idec Description and Business Overview
Table 54. Biogen Idec Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Biogen Idec Product
Table 56. Biogen Idec Recent Development
Table 57. Sangamo BioSciences Inc. Corporation Information
Table 58. Sangamo BioSciences Inc. Description and Business Overview
Table 59. Sangamo BioSciences Inc. Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Sangamo BioSciences Inc. Product
Table 61. Sangamo BioSciences Inc. Recent Development
Table 62. Genetix Pharmaceuticals/Bluebird Bio Corporation Information
Table 63. Genetix Pharmaceuticals/Bluebird Bio Description and Business Overview
Table 64. Genetix Pharmaceuticals/Bluebird Bio Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Genetix Pharmaceuticals/Bluebird Bio Product
Table 66. Genetix Pharmaceuticals/Bluebird Bio Recent Development
Table 67. Global Blood Therapeutics Inc. Corporation Information
Table 68. Global Blood Therapeutics Inc. Description and Business Overview
Table 69. Global Blood Therapeutics Inc. Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Global Blood Therapeutics Inc. Product
Table 71. Global Blood Therapeutics Inc. Recent Development
Table 72. Pfizer Inc. Corporation Information
Table 73. Pfizer Inc. Description and Business Overview
Table 74. Pfizer Inc. Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Pfizer Inc. Product
Table 76. Pfizer Inc. Recent Development
Table 77. Mast Therapeutics Corporation Information
Table 78. Mast Therapeutics Description and Business Overview
Table 79. Mast Therapeutics Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Mast Therapeutics Product
Table 81. Mast Therapeutics Recent Development
Table 82. Emmaus Life Sciences, Inc. Corporation Information
Table 83. Emmaus Life Sciences, Inc. Description and Business Overview
Table 84. Emmaus Life Sciences, Inc. Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Emmaus Life Sciences, Inc. Product
Table 86. Emmaus Life Sciences, Inc. Recent Development
Table 87. Prolong Pharmaceuticals Corporation Information
Table 88. Prolong Pharmaceuticals Description and Business Overview
Table 89. Prolong Pharmaceuticals Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Prolong Pharmaceuticals Product
Table 91. Prolong Pharmaceuticals Recent Development
Table 92. Celgene Corporation Corporation Information
Table 93. Celgene Corporation Description and Business Overview
Table 94. Celgene Corporation Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Celgene Corporation Product
Table 96. Celgene Corporation Recent Development
Table 97. HemaQuest Pharmaceuticals Corporation Information
Table 98. HemaQuest Pharmaceuticals Description and Business Overview
Table 99. HemaQuest Pharmaceuticals Hemoglobinopathies Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. HemaQuest Pharmaceuticals Product
Table 101. HemaQuest Pharmaceuticals Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Hemoglobinopathies Drugs Customers List
Table 105. Hemoglobinopathies Drugs Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemoglobinopathies Drugs Product Picture
Figure 2. Global Hemoglobinopathies Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Hemoglobinopathies Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Hemoglobinopathies Drugs Sales 2017-2028 (K Pcs)
Figure 5. United States Hemoglobinopathies Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Hemoglobinopathies Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Hemoglobinopathies Drugs Sales 2017-2028 (K Pcs)
Figure 8. United States Hemoglobinopathies Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Hemoglobinopathies Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Hemoglobinopathies Drugs Report Years Considered
Figure 11. Product Picture of Thalassemia Therapy
Figure 12. Product Picture of Sickle Cell Disease(SCD) Therapy
Figure 13. Product Picture of Other Therapy
Figure 14. Global Hemoglobinopathies Drugs Market Share by Type in 2022 & 2028
Figure 15. Global Hemoglobinopathies Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Hemoglobinopathies Drugs Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Hemoglobinopathies Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 18. Global Hemoglobinopathies Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Hemoglobinopathies Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 20. United States Hemoglobinopathies Drugs Market Share by Type in 2022 & 2028
Figure 21. United States Hemoglobinopathies Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Hemoglobinopathies Drugs Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Hemoglobinopathies Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 24. United States Hemoglobinopathies Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Hemoglobinopathies Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 26. Product Picture of Alpha Thalassemia
Figure 27. Product Picture of Beta thalassemia
Figure 28. Product Picture of Sickle Cell Disease
Figure 29. Product Picture of Hb Variants Diseases
Figure 30. Global Hemoglobinopathies Drugs Market Share by Application in 2022 & 2028
Figure 31. Global Hemoglobinopathies Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Hemoglobinopathies Drugs Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Hemoglobinopathies Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 34. Global Hemoglobinopathies Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Hemoglobinopathies Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 36. United States Hemoglobinopathies Drugs Market Share by Application in 2022 & 2028
Figure 37. United States Hemoglobinopathies Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Hemoglobinopathies Drugs Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Hemoglobinopathies Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 40. United States Hemoglobinopathies Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Hemoglobinopathies Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 42. North America Hemoglobinopathies Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 43. North America Hemoglobinopathies Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Hemoglobinopathies Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 47. Europe Hemoglobinopathies Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Hemoglobinopathies Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 54. Asia-Pacific Hemoglobinopathies Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Hemoglobinopathies Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 66. Latin America Hemoglobinopathies Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Hemoglobinopathies Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 71. Middle East & Africa Hemoglobinopathies Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. UAE Hemoglobinopathies Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Hemoglobinopathies Drugs Value Chain
Figure 76. Hemoglobinopathies Drugs Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed